NRC National Research Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: NRC

Price (delayed)

$19.72

Market cap

$444.42M

P/E Ratio

51.89

Dividend/share

$0.56

EPS

$0.38

Enterprise value

$519.91M

?
Relative Growth: Rel. Growth: 18
Relative Strength: Rel. Strength: 79
Relative Valuation: Rel. Valuation: 33
Relative Profitability: Rel. Profitability: 74

NRC Health is the leading provider of in-depth customer insights in healthcare.

Highlights
The gross margin has grown by 2.5% year-on-year
The stock's price to earnings (P/E) is 77% more than its 5-year quarterly average of 28.3 and 64% more than its last 4 quarters average of 30.5
The EPS has dropped by 63% year-on-year and by 24% since the previous quarter
Sector: Healthcare
Industry: Health Information Services
Website: http://nrchealth.com

Key stats

What are the main financial stats of NRC

NRC stock price

How has the National Research stock price performed over time
Intraday
3.57%
1 week
0.31%
1 month
8.23%
1 year
39.96%
YTD
5.06%
QTD
16.14%

Financial performance

How have National Research's revenue and profit performed over time
Revenue
$138.64M
Gross profit
$85.68M
Operating income
$19.56M
Net income
$9.04M
Gross margin
61.8%
Net margin
6.5%
NRC's net income has shrunk by 63% YoY and by 22% QoQ
National Research's net margin has shrunk by 62% YoY and by 23% QoQ
NRC's operating income is down by 44% YoY and by 13% QoQ
National Research's operating margin has decreased by 43% YoY and by 14% QoQ

Price vs fundamentals

How does NRC's price correlate with its fundamentals

Growth

What is National Research's growth rate over time

Valuation

What is National Research stock price valuation
NRC P/E details
P/E
51.89
P/B
33.24
P/S
3.1
EV/EBIT
26.5
EV/EBITDA
18.66
EV/Sales
3.75
The stock's price to earnings (P/E) is 77% more than its 5-year quarterly average of 28.3 and 64% more than its last 4 quarters average of 30.5
The EPS has dropped by 63% year-on-year and by 24% since the previous quarter
NRC's price to book (P/B) is 91% more than its 5-year quarterly average of 16.8 and 32% more than its last 4 quarters average of 24.4
National Research's equity has shrunk by 55% YoY and by 3.5% QoQ
The P/S is 44% lower than the 5-year quarterly average of 5.3 but 15% higher than the last 4 quarters average of 2.6

Efficiency

How efficient is National Research business performance
The return on assets has dropped by 65% year-on-year and by 22% since the previous quarter
NRC's return on invested capital has dropped by 61% year-on-year and by 16% since the previous quarter
The return on sales has declined by 43% year-on-year and by 14% since the previous quarter
NRC's return on equity is down by 20% year-on-year and by 2.1% since the previous quarter

Dividends

What is NRC's dividend history
Dividend details
DPS
$0.56
Dividend yield
2.84%
Payout ratio
147.4%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did National Research financials performed over time
NRC's total assets is 11% greater than its total liabilities
The quick ratio has declined by 17% since the previous quarter and by 5% year-on-year
National Research's total liabilities has increased by 15% YoY
NRC's debt to equity has soared by 163% YoY and by 2.3% QoQ
National Research's equity has shrunk by 55% YoY and by 3.5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.